CLINICAL TRIALS PROFILE FOR GLYNASE
✉ Email this page to a colleague
All Clinical Trials for GLYNASE
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00759720 ↗ | Efficacy and Safety of TAK-559 Combined With Glyburide in Treating Subjects With Type 2 Diabetes Mellitus. | Terminated | Takeda | Phase 3 | 2003-11-01 | The purpose of this study is to determine the safety and efficacy of TAK-559, once daily (QD), combined with glyburide in treating Type 2 Diabetes. |
NCT00770835 ↗ | Efficacy and Safety of Pioglitazone in Treating Subjects With Vascular Complications Associated With Type 2 Diabetes Mellitus. | Completed | Takeda | Phase 4 | 2009-03-01 | The purpose of this study is to determine the efficacy of pioglitazone compared to glibenclamide, once daily (QD), taken together with metformin and lifestyle modification in type 2 diabetic subjects with cardiovascular disease. |
NCT02726490 ↗ | Glyburide vs Glucovance in the Treatment of GDM | Terminated | Texas Tech University Health Sciences Center, El Paso | Early Phase 1 | 2016-07-01 | A randomized comparison of glyburide to glucovance (metformin -glyburide) in the management of diabetes in pregnancy. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for GLYNASE
Condition Name
Clinical Trial Locations for GLYNASE
Trials by Country
Clinical Trial Progress for GLYNASE
Clinical Trial Phase
Clinical Trial Sponsors for GLYNASE
Sponsor Name